Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
Active, not recruiting · NCT06695832 · Registry updated 2024-11-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia | Staphylococcus Aureus Bacteremia | Active, not recruiting | Not stated | 2024-11-22 | NCT06695832 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospital Universitari de Bellvitge | 49 |
| Institut d'Investigació Biomèdica de Bellvitge | 19 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Germans Trias i Pujol Research Institute and Hospital (IGTP) | Badalona | Spain | 1 |
| Hospital Clinic de Barcelona | Barcelona | Spain | 11 |
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | 20 |
| Hospital Universitari de Bellvitge | L'Hospitalet de Llobregat | Spain | 25 |
| Institute of Health Policy, Management and Evaluation, University of Toronto | Toronto | Canada | 1 |
| The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity | Melbourne | Australia | 1 |